O'Brien S - Search Results

1

Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199).

Patel VM, Balakrishnan K, Douglas M, Tibbitts T, Xu EY, Kutok JL, Ayers M, Sarkar A, Guerrieri R, Wierda WG, O'Brien S, Jain N, Stern HM, Gandhi V. Patel VM, et al. Leukemia. 2017 Sep;31(9):1872-1881. doi: 10.1038/leu.2016.382. Epub 2016 Dec 26. Leukemia. 2017. PMID: 28017967 Free PMC article. Clinical Trial.

2

Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia.

del Giglio A, O'Brien S, Ford R, Saya H, Manning J, Keating M, Johnston D, Khetan R, el-Naggar A, Deisseroth A. del Giglio A, et al. Blood. 1992 May 15;79(10):2717-20. Blood. 1992. PMID: 1350226 Free article.

3

New drugs in the treatment of chronic lymphocytic leukemia.

Keating MJ, O'Brien S, Robertson L, Plunkett W, Kantarjian H, Koller C. Keating MJ, et al. Leukemia. 1992 Nov;6 Suppl 4:140-1. Leukemia. 1992. PMID: 1359203 No abstract available.

4

Evolution of treatment for acute myelogenous leukemia and myelodysplastic syndrome at M.D. Anderson Cancer Center 1985-1991.

Keating MJ, Estey E, Kantarjian H, Plunkett W, O'Brien S, Koller C, Beran M, Freireich EJ. Keating MJ, et al. Leukemia. 1992;6 Suppl 2:78-80. Leukemia. 1992. PMID: 1578950 Review. No abstract available.

5

Erythropoietin treatment in patients with myelodysplastic syndrome and anemia.

Kurzrock R, Talpaz M, Estey E, O'Brien S, Estrov Z, Gutterman JU. Kurzrock R, et al. Leukemia. 1991 Nov;5(11):985-90. Leukemia. 1991. PMID: 1961041

6

Fludarabine phosphate: a new active agent in hematologic malignancies.

Keating MJ, O'Brien S, Plunkett W, Robertson LE, Gandhi V, Estey E, Dimopoulos M, Cabanillas F, Kemena A, Kantarjian H. Keating MJ, et al. Semin Hematol. 1994 Jan;31(1):28-39. Semin Hematol. 1994. PMID: 7510070 Review. No abstract available.

7

The expanding role of fludarabine in hematologic malignancies.

Keating MJ, O'Brien S, Robertson LE, Kantarjian H, Dimopoulos M, McLaughlin P, Cabanillas F, Gregoire V, Li YY, Gandhi V, et al. Keating MJ, et al. Leuk Lymphoma. 1994;14 Suppl 2:11-6. doi: 10.3109/10428199409052690. Leuk Lymphoma. 1994. PMID: 7533576 Review.

8

Fludarabine plus doxorubicin in previously treated chronic lymphocytic leukemia.

Robertson LE, O'Brien S, Kantarjian H, Koller C, Beran M, Andreeff M, Lerner S, Keating MJ. Robertson LE, et al. Leukemia. 1995 Jun;9(6):943-5. Leukemia. 1995. PMID: 7596181 Clinical Trial.

9

Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.

Marlton P, Keating M, Kantarjian H, Pierce S, O'Brien S, Freireich EJ, Estey E. Marlton P, et al. Leukemia. 1995 Jun;9(6):965-71. Leukemia. 1995. PMID: 7596186

10

Interferon maintenance therapy for patients with chronic lymphocytic leukemia in remission after fludarabine therapy.

O'Brien S, Kantarjian H, Beran M, Robertson LE, Koller C, Lerner S, Keating MJ. O'Brien S, et al. Blood. 1995 Aug 15;86(4):1298-300. Blood. 1995. PMID: 7632936 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,119 results

Search Page

Filters